Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H).
Teva Presents Data Comparing Early Treatment with COPAXONE® 40 mg/mL to Delayed Start Treatment at 67th American Academy of Neurology (AAN) Annual Meeting in Washington, D.C.
Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS.
Does interferon Beta-1a impact pure-tone hearing sensitivity among individuals with multiple sclerosis?
Monoclonal antibodies conjugated with superparamagnetic iron oxide particles allow magnetic resonance imaging detection of lymphocytes in the mouse brain.
Simvastatin as add-on therapy to interferon β-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial.
Glatiramer acetate does not protect from acute ischemic stroke in mice.
Genzyme's Lemtrada resubmission accepted for review by FDA
Apitope Announces Positive Results from Clinical Trial of ATX-MS-1467 in Relapsing Multiple Sclerosis
Pediatric multiple sclerosis.
Significant Percentage of MS Patients Receiving Alemtuzumab in Genzyme’s Phase 2 Trial Remain Free of Clinically Active Disease
Gut microbiota composition and relapse risk in pediatric MS: A pilot study.
CNS myelin wrapping is driven by actin disassembly.
Multiple associations between a broad spectrum of autoimmune diseases, chronic inflammatory diseases and cancer.
Design, engineering, and production of human recombinant t cell receptor ligands derived from human leukocyte antigen DR2.
In vivo gene expression revealed by cDNA arrays: the pattern in relapsing-remitting multiple sclerosis patients compared with normal subjects.
Changes to anti-JCV antibody levels in a Swedish national MS cohort.
Activation of axonal Kv7 channels in human peripheral nerve by flupirtine but not placebo - therapeutic potential for peripheral neuropathies: results of a randomised controlled trial.
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
Emerging roles of endothelial cells in multiple sclerosis pathophysiology and therapy.
Treatment with 4-aminopyridine improves upper limb tremor of a patient with multiple sclerosis: a video case report.
Molecular properties of epithelial, amiloride-blockable Na+ channels.
A complex role of herpes viruses in the disease process of multiple sclerosis.
Disease-modifying treatments for progressive multiple sclerosis.
The Stigma Scale for Chronic Illnesses 8-Item Version (SSCI-8): Development, Validation and Use Across Neurological Conditions.

Pages